<DOC>
	<DOCNO>NCT00838045</DOCNO>
	<brief_summary>This study evaluate safety effectiveness Bausch &amp; Lomb Akreos TL ( thin lens ) intraocular lens ( IOL ) follow implantation adult require cataract surgery .</brief_summary>
	<brief_title>Evaluation Safety &amp; Effectiveness Bausch &amp; Lomb AKREOSÂ® TL Intraocular Lens</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Aphakia</mesh_term>
	<criteria>Subjects must clinically document diagnosis agerelated cataract consider amenable treatment standard phacoemulsification/extracapsular cataract extraction . Subjects must undergo primary intraocular lens implantation correction aphakia follow continuous curvilinear anterior capsulotomy phacoemulsification cataract extraction . Subjects must require lens power 15 30 diopter . Subjects must visual potential 20/40 good study eye . Subjects anterior segment pathology extracapsular phacoemulsification cataract surgery would contraindicate . Subjects inflammation edema ( swell ) cornea . Subjects uncontrolled glaucoma glaucoma current treatment study eye ocular hypertension . Subjects previous retinal detachment . Subjects diabetic retinopathy ( proliferative nonproliferative ) . Subjects rubella , bilateral congenital , traumatic , complicate cataract . Subjects previous ocular surgery plan operative eye , exclude ocular adnexa surgery . Subjects already receive Akreos TL IOL fellow eye .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>